Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Conflict of interest: no such thing as a free lunch.

Isaacs D.

J Paediatr Child Health. 2011 Oct;47(10):679-80. doi: 10.1111/j.1440-1754.2011.02085.x. No abstract available.

PMID:
21999442
2.

Pharmaceutical industry support for continuing medical education: is it time to disengage?

Kerridge I.

J Paediatr Child Health. 2011 Oct;47(10):690-2. doi: 10.1111/j.1440-1754.2011.02191.x. No abstract available.

PMID:
21999444
3.

The medical-industrial complex and conflict of interest in pain education.

Schatman ME.

Pain Med. 2011 Dec;12(12):1710-2. doi: 10.1111/j.1526-4637.2011.01284.x. No abstract available.

PMID:
22168303
4.

Continuing medical education and pharmaceutical industry.

Vakani FS, Jafri W, Amin A, Sheerani M.

J Coll Physicians Surg Pak. 2011 Jun;21(6):360-1. doi: 07.2011/JCPSP.360361.

PMID:
21711993
5.

Conflicts of interest.

Ripps RA.

Conn Med. 2009 Jan;73(1):37-8. No abstract available.

PMID:
19248573
6.

[Drug companies and continuing education].

Hotvedt R.

Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2043. Norwegian. No abstract available.

7.

Continuing medical education programs being placed under closer scrutiny.

Wilson B.

CMAJ. 2010 Oct 5;182(14):E683-4. doi: 10.1503/cmaj.109-3318. No abstract available.

8.

Must "no see" always mean a "no know"?

Gamble GL.

PM R. 2009 Jan;1(1):87-8. doi: 10.1016/j.pmrj.2008.11.004. No abstract available.

PMID:
19627879
9.

US accrediting agency tightens rules for continuing medical education.

Tanne JH.

BMJ. 2004 Oct 9;329(7470):819. No abstract available.

10.

[The medical-industrial complex: an ethical challenge].

Engelhardt K.

Dtsch Med Wochenschr. 2005 Jul 29;130(30):1778-80. German. No abstract available.

PMID:
16049885
11.

Current guidelines regarding industry-sponsored continuing medical education.

DelSignore JL.

Clin Orthop Relat Res. 2003 Jul;(412):21-7. Review.

PMID:
12838047
12.

Rebuttal: Is CME a drug-promotion tool?: NO.

Marlow B.

Can Fam Physician. 2007 Nov;53(11):1877, 1878-9. English, French. No abstract available.

13.

Rebuttal: Is CME a drug-promotion tool?: YES.

Steinman MA, Baron RB.

Can Fam Physician. 2007 Nov;53(11):1877, 1878-9. English, French. No abstract available.

14.

Pharmaceutical industry financial support for medical education: benefit, or undue influence?

Brody H.

J Law Med Ethics. 2009 Fall;37(3):451-60, 396. doi: 10.1111/j.1748-720X.2009.00406.x.

PMID:
19723256
15.

[Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].

Miyata Y.

Seishin Shinkeigaku Zasshi. 2010;112(11):1136-45. Review. Japanese.

PMID:
21226250
16.
17.

Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.

Romano M.

Mod Healthc. 2006 Jan 30;36(5):8-10. No abstract available.

PMID:
16479773
18.

Individual wariness needed to spot biased drug research.

Lazarus A.

Manag Care. 2005 Sep;14(9):8, 13. No abstract available.

19.

Continuing medical education: ethical collaboration between sponsor and industry.

Wilson FS.

Clin Orthop Relat Res. 2003 Jul;(412):33-7. Review.

PMID:
12838049
20.

Funding for continuing medical education.

Marlow BA, Mongeau I, Stern S, Murray S.

CMAJ. 2008 Jun 3;178(12):1576; author reply 1578. doi: 10.1503/cmaj.1080047. No abstract available.

Items per page

Supplemental Content

Support Center